tiprankstipranks
CURE Pharmaceutical Holding Corp. (CURR)
OTHER OTC:CURR
US Market

CURE Pharmaceutical Holding (CURR) Financial Statements

36 Followers

CURE Pharmaceutical Holding Financial Overview

CURE Pharmaceutical Holding's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; CURE Pharmaceutical Holding is scheduled to report earnings on August 15, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 1.24M$ 886.00K$ 1.78M$ 1.12M$ 1.10M
Gross Profit$ 977.00K$ 188.00K$ 1.43M$ 973.00K$ 750.00K
EBIT$ -195.00K$ -182.00K$ -3.47M$ -6.74M$ -4.96M
EBITDA$ -157.00K$ -65.00K$ -3.22M$ -6.53M$ -3.96M
Net Income Common Stockholders$ -209.00K$ -7.15M$ -3.59M$ -9.62M$ -5.15M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.44M$ 2.94M$ 4.44M$ 51.00K$ 531.00K
Total Assets$ 5.20M$ 6.85M$ 14.96M$ 29.32M$ 37.32M
Total Debt$ 109.00K$ 331.00K$ 237.00K$ 13.53M$ 15.66M
Net Debt$ -1.33M$ -2.61M$ -4.21M$ 13.48M$ 15.13M
Total Liabilities$ 12.30M$ 13.96M$ 15.14M$ 26.43M$ 25.23M
Stockholders Equity$ -7.10M$ -7.11M$ -173.00K$ 2.89M$ 12.10M
Cash Flow-
Free Cash Flow$ -1.44M$ 12.30M$ -4.92M$ -1.74M$ -1.83M
Operating Cash Flow$ -1.41M$ -1.59M$ -4.92M$ -1.74M$ -1.83M
Investing Cash Flow$ -35.00K$ -54.00K$ 13.89M$ 0.00$ 0.00
Financing Cash Flow$ -63.00K$ 140.00K$ -4.58M$ 1.26M$ 2.35M
Currency in USD

CURE Pharmaceutical Holding Earnings and Revenue History

CURE Pharmaceutical Holding Debt to Assets

CURE Pharmaceutical Holding Cash Flow

CURE Pharmaceutical Holding Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis